PLD and PA Take MT1-MMP for a Metastatic Ride

Narendra Thapa1, Richard A Anderson1

  • 1University of Wisconsin-Madison, School of Medicine and Public Health, 1300 University Avenue, Madison, WI 53706, USA.

Developmental Cell
|October 25, 2017
PubMed

Insights

A novel signaling molecule from phospholipase D2 directs the deposition of MT1-MMP, a key protein in metastasis. This finding is crucial for understanding breast cancer progression and developing new therapeutic strategies.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Biochemistry

Background:

  • Polarized targeting and deposition of membrane type 1-matrix metalloproteinase (MT1-MMP) are essential processes for cancer cell invasion and metastasis.
  • Understanding the regulatory mechanisms controlling MT1-MMP localization is critical for deciphering cancer progression.

Purpose of the Study:

  • To identify the signaling molecules and pathways responsible for the polarized deposition of MT1-MMP at invadopodia.
  • To elucidate the role of phospholipase D2 in regulating MT1-MMP localization and its contribution to breast cancer metastasis.

Main Methods:

  • Utilized a transgenic breast cancer model.
  • Investigated the role of phospholipase D2 and its downstream signaling molecules.
  • Analyzed the localization and function of MT1-MMP in invadopodia formation.

Main Results:

  • Discovered that a signaling molecule generated by phospholipase D2 is critical for MT1-MMP deposition at invadopodia.
  • Demonstrated that this pathway is essential for metastasis in a preclinical breast cancer model.
  • Established a direct link between phospholipase D2 activity and MT1-MMP-driven invasion.

Conclusions:

  • Phospholipase D2-generated signaling molecules play a pivotal role in directing MT1-MMP to invadopodia, thereby promoting breast cancer metastasis.
  • Targeting this pathway could offer a novel therapeutic strategy for inhibiting cancer spread.